What are targeted anti-cancer drugs?

Written by: Dr Omar Din
Published: | Updated: 11/09/2023
Edited by: Conor Lynch

Top Doctors recently spoke to highly revered consultant clinical oncologist, Dr Omar Din, who, here in our latest medical article, describes what exactly targeted anticancer drugs are, and reveals when targeted drug therapy is recommended.

What is a targeted anti-cancer drug?

Targeted anti-cancer drugs work against specific ways cancer cells use to grow and survive. They are used in the treatment of several cancers, particularly those that have spread.

 

There are many different types of targeted drugs. These are grouped together depending on how they work. These groups include antibody therapy (monoclonal antibodies), cancer growth blockers, drugs that block cancer blood vessel growth, and drugs that stop damaged cancer cells repairing themselves. A specific type of targeted antibody therapy is immunotherapy, which encourages the immune system to attack cancer cells.

 

How do targeted anticancer drugs compare to other cancer treatments?

Targeted anti-cancer drugs are different to chemotherapy in both the way they work and their side-effects. Targeted drugs usually focus on blocking, for example, a specific growth signal, leading to cell death.

 

Chemotherapy is more general in killing cells that are actively dividing. Given most cancer cells divide more rapidly, chemotherapy has a greater impact on these than normal cells. The main difference in side effects is that chemotherapy usually dampens down the immune system (increasing the risk of infection), whereas most targeted therapies have different (but equally important) side-effects.

 

When is targeted drug therapy recommended?

Targeted anti-cancer drug therapy is usually recommended in specific cancers with a specific target involved in cancer cell growth or survival. It can also depend on whether or not the cancer has spread, or if other treatments have already been received.

 

These drugs have usually been thoroughly evaluated in specific cancers, showing a clear benefit in clinical trials. Some cancers need a specific test to see if they carry the right target, but this is not always necessary.

 

How successful is targeted drug therapy?

Clinical trials have shown significant benefits from the use of targeted drugs in certain cancers. They have the potential to reduce the risk of recurrence after radical curative treatment. In addition, for certain cancers that have spread, they have been shown to improve quality of life and delay progression.

 

What are some examples of novel targeted anticancer drug treatments?

Some examples of targeted drugs are shown below:

 

  1. Monoclonal antibodies.
  2. Drugs that block the growth of cancers. 
  3. Drugs that block cancer blood vessel growth.
  4. Hormone therapy
  5. PARP inhibitors.

 

Dr Omar Din is a highly respected and experienced consultant clinical oncologist who specialises in cancer diagnosis and treatment. Consult with him today via his Top Doctors profile.

By Dr Omar Din
Clinical oncology

Dr Omar Din (Shujja-Ud-Din) is an expert consultant clinical oncologist with over 20 years of experience, practising at Sheffield Oncology at Thornbury Hospital, Sheffield. Dr Din is highly experienced in the treatment of many types of cancer, especially prostate, bladder, kidney, and breast cancer with some of the most advanced non-surgical treatment techniques using radiotherapy and chemotherapy.  

Graduating from the University of Sheffield in 1997, Dr Din went on to complete specialist training in clinical oncology at Weston Park Cancer Centre in Sheffield and Christie Hospital in Manchester. After undertaking a clinical research fellowship in breast cancer endocrine therapy, Dr Din was awarded an MD for his research at Sheffield and Leeds Cancer Centres from the University of Sheffield in 2010.  

Dr Din was then appointed as a consultant and honorary senior lecturer in clinical oncology in 2010 at the Sheffield Teaching Hospitals NHS Foundation Trust. Before joining Sheffield Oncology, Dr Din was the lead clinician and strategic lead for radiotherapy at Weston Park Cancer Centre. He prides his clinical work on the provision of the most cutting-edge treatments for his patients.  

Additionally, he remains actively involved in clinical trials and research and has been the local principal investigator on several national clinical trials. He has been a fellow of the Royal College of Radiologists since 2005. He is responsible for the training of junior doctors, medical students, and advanced clinical practitioners.  

View Profile

Overall assessment of their patients


  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.